It is generally accepted that vasculitis is produced by the deposition of circulating immune complexes (CIC) in blood vessel walls. This paper presents our findings relating to CIC in idiopathic cutaneous or systemic vasculitis. An attempt has been made to determine whether or not there is any correlation between the presence of CIC in the serum and the clinical state of the patients and the apparent organ involvement in the disease and also to relate the constituents of the CIC with the proteins present in the blood vessel walls.
Material and methods
Patients. A total of 36 patients were studied, and in 8 
Discussion
This study confirms the findings of other groups that circulating immune complexes are detectable in a high proportion of patients with vasculitis. [2] [3] [4] The incidence and amount of circulating complexes did not, however, appear to be related to clinical and laboratory evidence of organ involvement or to the extent of complement activation. On the other hand serial measurement of CIC in 8 patients with systemic vasculitis showed a fall to normal of CIC levels in serum in association with a favourable response to prednisolone treatment. In 3 of these patients a relapse of the condition was associated with a rise in CIC and a subsequent fall with increased prednisolone dosage.
The serial measurements of CIC during treatment of systemic vasculitis reported here expands the information already available from this laboratory. 5 There are no other reports of such studies, and the findings may be taken as further evidence for a pathogenetic role of CIC in vasculitis. Nevertheless the lack of correlation between CIC levels and extent of organ involvement raises the possibility that such a conclusion may be too simplistic. One of the patients with systemic vasculitis who was treated with prednisolone showed raised CIC for 2 months despite prompt and maintained response to treatment, and in addition 2 of the cases of cutaneous vasculitis were studied in the presence and in the absence of a rash and there was no difference in the levels of GIC. Thus under some circumstances CIC may be present, but do not appear to cause vascular inflammation.
A number of factors have been shown to determine whether or not CIC deposit in tissues in experimental models of immune complex disease. These include size of CIC6 and complement-mediated changes.7 Molecular size analysis of CIC from serum of 6 There is no evidence that our monoclonal rheumatoid factor reacts preferentially with complexes of a particular molecular size,5 but it is IgG specific. It is thus also possible that predominantly IgM-containing CIC were present in the 2 patients in whom no >1 -106 dalton RFB material was found. Some evidence for the existence of such CIC is available from the study of Burden et al. 8 Kaufman et al. 4 showed that a good correlation existed between the constituents of circulating and tissue immune complexes in some forms of vasculitis. We were able to analyse the constituents in only a small number of patients with high RFB serum. 
